ReCode Therapeutics’ $120 Million Series B Financing

Wilson Sonsini Goodrich & Rosati represented ReCode Therapeutics in the transaction.ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of messenger…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now